Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVF trigger comparison with GnRH agonist, hCG, and dual trigger in antagonist protocol
IRCT20160130026260N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of triptorelin and human chorionic gonadotropin in female infertility (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Clinical pregnancy rate. Started Mar 2020; status: completed.
02
Drugs
triptorelinhuman chorionic gonadotropin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20160130026260N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160130026260N2.